Munawar Alavi, MD
Cardiovascular Disease (Cardiology) · San Jose
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 33
- 9 carriers
- Office
- 1
On the public record
- California licence: Delinquent
Offices
1 location
Plans that list them
33 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Alavi’s office at (408) 770-3102 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
33 of 33 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A32226 · Delinquent
Licence status: Delinquent · since 1978 · expires 2025-11-30 · Mysore University, Mysore Medical College.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$138,259
Medicare paid this office $138,259 for 360 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 182 | $35,377 | $88 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 80 | $17,212 | $212 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 70 | $16,126 | $75 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 81 | $15,721 | $165 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 121 | $8,363 | $66 |
See all 16 services
| Short return visit (20+ min) | 182 | $35,377 | $88 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 80 | $17,212 | $212 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 70 | $16,126 | $75 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 81 | $15,721 | $165 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 121 | $8,363 | $66 |
| Return visit (30+ min) | 45 | $7,121 | $119 |
| New patient visit (45+ min) | 42 | $6,417 | $153 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 26 | $3,976 | $76 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 38 | $2,817 | $74 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 34 | $2,753 | $79 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 164 | $2,697 | $14 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 12 | $2,522 | $210 |
| Programming of dual lead pacemaker system | 16 | $1,822 | $83 |
| Injection of drug or substance into vein | 27 | $1,136 | $42 |
| Injection, regadenoson, 0.1 mg | 15 | $547 | None |
| Infusion, normal saline solution, 250 cc | 27 | $14 | None |
Procedures Medicare counted
| Coronary angioplasty and stenting | 16 | More than 41% of doctors who do this |
| Pacemaker insertion or repair | 1-10 | None |
Who their Medicare patients are
360 Original Medicare patients in 2024. Average age 79 · Under 65 7% · 85 and older 32% · Women 55% · Also on Medicaid 62% · Health risk score 2.17. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Diabetes 63% · Chronic kidney disease 44% · Coronary heart disease 43% · Atrial fibrillation 40% · Heart failure 36% · Dementia 24% · COPD 23% · Stroke 22% · Depression 19% · Cancer 13%.
The office billed $357,492, Medicare allowed $178,519 and paid $138,259; for 1,614 services of 47 kinds; $575 of it was for drugs given in the office and $137,683 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 360 | 1,614 | 79 | 2.17 | $357,492 | $138,259 |
| 2023 | 391 | 1,943 | 78 | 1.97 | $368,680 | $135,623 |
| 2022 | 447 | 2,815 | 79 | 2.50 | $388,287 | $144,729 |
| 2021 | 463 | 3,169 | 77 | 2.33 | $486,457 | $190,134 |
| 2020 | 529 | 3,513 | 77 | 2.61 | $544,757 | $204,819 |
| 2019 | 528 | 4,788 | 77 | 2.53 | $639,179 | $231,466 |
| 2018 | 471 | 3,832 | 77 | 2.52 | $547,887 | $219,825 |
| 2017 | 425 | 3,698 | 77 | 2.23 | $473,804 | $166,610 |
| 2016 | 601 | 5,172 | 76 | 2.47 | $812,030 | $295,658 |
| 2015 | 678 | 6,548 | 76 | 2.18 | $937,881 | $338,163 |
| 2014 | 682 | 4,989 | 77 | 2.04 | $917,871 | $310,786 |
| 2013 | 647 | 3,294 | 77 | 2.18 | $814,005 | $274,544 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 19 services
| Short return visit (20+ min) | 190 | $31,957 | $80 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 67 | $17,596 | $72 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 64 | $12,773 | $200 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 74 | $11,414 | $152 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 22 | $10,331 | $470 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 137 | $8,726 | $62 |
| Return visit (30+ min) | 48 | $7,764 | $119 |
| New patient visit (45+ min) | 31 | $4,549 | $147 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 25 | $3,811 | $76 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 43 | $3,184 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $2,796 | $108 |
| Injection, regadenoson, 0.1 mg | 15 | $2,751 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 31 | $2,002 | $65 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 131 | $1,910 | $13 |
| Programming of dual lead pacemaker system | 17 | $1,888 | $73 |
| Injection of drug or substance into vein | 25 | $992 | $40 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 12 | $231 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 12 | $152 | $13 |
| Infusion, normal saline solution, 250 cc | 25 | $13 | None |
2022: 20 services
| Short return visit (20+ min) | 183 | $30,546 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 96 | $20,024 | $179 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 81 | $19,238 | $64 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 28 | $13,696 | $489 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 191 | $12,326 | $63 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 51 | $10,687 | $202 |
| Return visit (30+ min) | 57 | $8,292 | $114 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 28 | $4,862 | $87 |
| New patient visit (45+ min) | 30 | $4,163 | $139 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 12 | $3,052 | $235 |
| Programming of dual lead pacemaker system | 23 | $2,655 | $83 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 36 | $2,142 | $60 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 29 | $2,027 | $68 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 125 | $1,774 | $13 |
| Short return visit | 24 | $1,220 | $47 |
| Injection of drug or substance into vein | 28 | $1,178 | $42 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 27 | $440 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 15 | $278 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 15 | $220 | $13 |
| Infusion, normal saline solution, 250 cc | 28 | $15 | None |
2021: 23 services
| Short return visit (20+ min) | 184 | $30,857 | $85 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 133 | $29,006 | $182 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 113 | $27,695 | $66 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 75 | $15,619 | $208 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 28 | $14,718 | $526 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 185 | $12,725 | $65 |
| Return visit (30+ min) | 74 | $10,201 | $119 |
| New patient visit (45+ min) | 38 | $5,690 | $150 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 28 | $4,854 | $87 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 21 | $4,691 | $223 |
| Telephone medical discussion with physician, 11-20 minutes | 60 | $4,327 | $63 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 33 | $2,572 | $78 |
| Programming of dual lead pacemaker system | 22 | $2,528 | $77 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 35 | $2,348 | $65 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 146 | $2,343 | $13 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $2,095 | $95 |
| Injection of drug or substance into vein | 29 | $1,296 | $45 |
| Short return visit | 15 | $903 | $56 |
| Telephone medical discussion with physician, 5-10 minutes | 14 | $621 | $44 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 28 | $520 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 21 | $427 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 21 | $287 | $14 |
| Infusion, normal saline solution, 250 cc | 29 | $20 | None |
2020: 24 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 137 | $36,849 | $67 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 148 | $31,986 | $186 |
| Short return visit (20+ min) | 181 | $16,953 | $61 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 230 | $16,454 | $69 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 68 | $14,320 | $211 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 22 | $11,130 | $506 |
| Return visit (30+ min) | 82 | $10,640 | $101 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 11 | $7,079 | $472 |
| Telephone medical discussion with physician, 11-20 minutes | 79 | $6,681 | $72 |
| New patient visit (45+ min) | 45 | $6,637 | $147 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 24 | $6,135 | $227 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 25 | $4,504 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $3,395 | $97 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 39 | $2,669 | $67 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 139 | $2,597 | $16 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 25 | $1,898 | $76 |
| Programming of dual lead pacemaker system | 22 | $1,661 | $57 |
| Injection of drug or substance into vein | 28 | $1,187 | $42 |
| Telephone medical discussion with physician, 5-10 minutes | 23 | $1,127 | $45 |
| Short return visit | 20 | $873 | $44 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 28 | $613 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 25 | $523 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 25 | $351 | $14 |
| Infusion, normal saline solution, 250 cc | 28 | $25 | None |
2019: 20 services
| Short return visit (20+ min) | 242 | $33,295 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 147 | $32,488 | $184 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 131 | $27,593 | $66 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 45 | $23,099 | $502 |
| Return visit (30+ min) | 136 | $19,012 | $96 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 81 | $16,795 | $202 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 181 | $12,547 | $67 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 45 | $8,144 | $89 |
| New patient visit (45+ min) | 48 | $7,316 | $152 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 39 | $6,425 | $94 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 23 | $5,626 | $234 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 65 | $4,247 | $63 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 194 | $3,438 | $15 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 32 | $2,661 | $83 |
| Programming of dual lead pacemaker system | 28 | $2,524 | $60 |
| Injection of drug or substance into vein | 48 | $2,000 | $41 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 47 | $1,305 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 27 | $552 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 27 | $370 | $14 |
| Infusion, normal saline solution, 250 cc | 48 | $31 | None |
2018: 19 services
| Short return visit (20+ min) | 252 | $40,085 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 88 | $27,328 | $72 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 104 | $23,619 | $227 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 91 | $23,544 | $200 |
| Return visit (30+ min) | 148 | $22,223 | $98 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 32 | $18,045 | $564 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 133 | $9,738 | $72 |
| New patient visit (45+ min) | 42 | $6,905 | $164 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 32 | $6,124 | $96 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 196 | $3,820 | $16 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 39 | $3,597 | $92 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 47 | $3,465 | $71 |
| Programming of dual lead pacemaker system | 28 | $2,464 | $56 |
| Injection of drug or substance into vein | 34 | $1,851 | $53 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 30 | $816 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 27 | $596 | $22 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 27 | $400 | $15 |
| Blood test, clotting time | 11 | $266 | $5 |
| Infusion, normal saline solution, 250 cc | 34 | $29 | None |
2017: 18 services
| Short return visit (20+ min) | 255 | $32,319 | $64 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 138 | $31,026 | $223 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 48 | $24,280 | $496 |
| Return visit (30+ min) | 140 | $19,501 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 50 | $9,790 | $181 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 48 | $8,362 | $85 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 37 | $6,802 | $65 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 104 | $6,008 | $57 |
| New patient visit (45+ min) | 28 | $3,925 | $140 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 55 | $3,752 | $66 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 176 | $3,132 | $15 |
| Injection of drug or substance into vein | 48 | $2,840 | $58 |
| Programming of dual lead pacemaker system | 31 | $2,628 | $53 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 32 | $2,466 | $77 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 43 | $833 | None |
| Blood test, clotting time | 14 | $232 | $5 |
| Insertion of needle into vein for collection of blood sample | 13 | $106 | $3 |
| Infusion, normal saline solution, 250 cc | 48 | $19 | None |
2016: 24 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 197 | $42,477 | $179 |
| Short return visit (20+ min) | 288 | $40,912 | $63 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 152 | $34,862 | $225 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 156 | $31,957 | $64 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 63 | $31,491 | $500 |
| Return visit (30+ min) | 182 | $26,858 | $94 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 190 | $11,345 | $57 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 63 | $10,889 | $87 |
| New patient visit (45+ min) | 64 | $9,402 | $147 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 35 | $8,310 | $219 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 14 | $8,014 | $501 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 82 | $5,466 | $67 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 210 | $3,664 | $15 |
| Injection of drug or substance into vein | 63 | $3,663 | $58 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 38 | $3,255 | $83 |
| Ultrasound of both sides of head and neck blood flow | 13 | $2,558 | $197 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $2,315 | $93 |
| Programming of dual lead pacemaker system | 28 | $2,272 | $52 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 47 | $1,193 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 42 | $841 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 42 | $549 | $13 |
| Blood test, clotting time | 12 | $294 | $5 |
| Insertion of needle into vein for collection of blood sample | 12 | $141 | $3 |
| Infusion, normal saline solution, 250 cc | 63 | $24 | None |
2015: 23 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 235 | $49,336 | $179 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 92 | $45,951 | $499 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 191 | $43,681 | $64 |
| Short return visit (20+ min) | 261 | $34,889 | $62 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 132 | $29,755 | $219 |
| Return visit (30+ min) | 173 | $25,125 | $95 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 92 | $15,850 | $86 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 248 | $14,629 | $57 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 49 | $11,847 | $215 |
| New patient visit (45+ min) | 71 | $10,390 | $146 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 16 | $8,698 | $483 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 117 | $7,826 | $66 |
| Injection of drug or substance into vein | 92 | $5,386 | $58 |
| Programming of dual lead pacemaker system | 28 | $2,487 | $54 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 142 | $2,409 | $15 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 28 | $2,379 | $85 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 18 | $2,202 | $34 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 71 | $2,157 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 51 | $1,012 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 51 | $661 | $13 |
| Blood test, clotting time | 13 | $372 | $5 |
| Insertion of needle into vein for collection of blood sample | 12 | $168 | $3 |
| Infusion, normal saline solution, 250 cc | 93 | $30 | None |
2014: 26 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 213 | $51,399 | $64 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 100 | $50,228 | $497 |
| Short return visit (20+ min) | 312 | $45,136 | $61 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 184 | $25,420 | $119 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 94 | $19,786 | $204 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 220 | $13,082 | $57 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 50 | $12,552 | $251 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 68 | $12,231 | $180 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 73 | $12,195 | $87 |
| Return visit (30+ min) | 101 | $12,075 | $98 |
| New patient visit (45+ min) | 59 | $8,594 | $146 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 112 | $7,355 | $65 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 11 | $5,868 | $451 |
| Short return visit | 95 | $4,007 | $32 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 25 | $3,955 | $132 |
| Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) | 52 | $2,889 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 140 | $2,398 | $15 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 21 | $1,859 | $85 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $1,596 | $35 |
| Injection of drug or substance into vein | 27 | $1,543 | $57 |
| Programming of dual lead pacemaker system | 22 | $1,513 | $50 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 70 | $1,409 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 69 | $898 | $13 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 11 | $387 | $35 |
| Blood test, clotting time | 11 | $163 | $5 |
| Infusion, normal saline solution, 250 cc | 27 | $7 | None |
2013: 21 services
| Short return visit (20+ min) | 327 | $50,656 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 190 | $46,676 | $62 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 62 | $31,874 | $514 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 219 | $30,070 | $118 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 61 | $16,005 | $132 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 89 | $15,467 | $174 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 40 | $11,215 | $261 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 189 | $10,660 | $55 |
| Injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270) | 61 | $10,406 | None |
| New patient visit (45+ min) | 48 | $6,488 | $135 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 83 | $5,859 | $69 |
| Short return visit | 97 | $4,726 | $34 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 139 | $2,498 | $16 |
| Return visit (30+ min) | 24 | $2,294 | $96 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 26 | $2,282 | $85 |
| Programming of dual lead pacemaker system | 21 | $1,379 | $46 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 44 | $847 | $19 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $806 | $34 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 42 | $536 | $13 |
| Blood test, clotting time | 18 | $347 | $5 |
| Blood test, lipids (cholesterol and triglycerides) | 14 | $246 | $18 |
Medicaid work
$5,648 in 2024
Medicaid paid $5,648 for 488 billed services this clinician did in 2024, up to 43 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 159 | $2,817 |
| Short return visit (20+ min) | 250 | $1,996 |
| 1ST HOSP IP/OBS HIGH 75 | 14 | $389 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 36 | $291 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 29 | $155 |
| 2024 | 488 | 5 | 43 | $5,648 |
| 2023 | 684 | 3 | 56 | $4,087 |
| 2022 | 439 | 3 | 56 | $3,329 |
| 2021 | 577 | 5 | 52 | $7,366 |
| 2020 | 478 | 6 | 50 | $5,115 |
| 2019 | 250 | 4 | 27 | $2,588 |
| 2018 | 111 | 4 | 23 | $1,394 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 187 | $2,698 |
| Short return visit (20+ min) | 328 | $986 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 169 | $402 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 164 | $3,023 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 74 | $162 |
| Short return visit (20+ min) | 201 | $144 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 238 | $4,226 |
| 1ST HOSP IP/OBS HIGH 75 | 72 | $1,903 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 31 | $619 |
| Short return visit (20+ min) | 181 | $438 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 55 | $180 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 174 | $3,440 |
| 1ST HOSP IP/OBS HIGH 75 | 38 | $600 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 81 | $333 |
| Short return visit (20+ min) | 87 | $295 |
| New patient visit (45+ min) | 27 | $253 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 71 | $195 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 53 | $1,731 |
| Short return visit (20+ min) | 109 | $392 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 75 | $347 |
| New patient visit (45+ min) | 13 | $118 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 41 | $838 |
| Return visit (30+ min) | 13 | $290 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 40 | $246 |
| Short return visit (20+ min) | 17 | $21 |
Drugs they prescribed that Part D paid
$358,748
Pharmacies billed $358,748 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,030) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
1,750 generic and 280 brand-name prescriptions · $358,748 in drug cost · 17 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 119 | $157,572 | $1,324 |
| Entresto | 40 | $58,114 | $1,453 |
| Brilinta | 39 | $34,444 | $883 |
| Xarelto | 20 | $27,773 | $1,389 |
| Jardiance | 15 | $16,493 | $1,100 |
See all 39 drugs
| Eliquis | 119 | $157,572 | $1,324 |
| Entresto | 40 | $58,114 | $1,453 |
| Brilinta | 39 | $34,444 | $883 |
| Xarelto | 20 | $27,773 | $1,389 |
| Jardiance | 15 | $16,493 | $1,100 |
| Diltiazem 12hr Er | 33 | $5,505 | $167 |
| Dabigatran Etexilate | 15 | $3,642 | $243 |
| Metoprolol | 168 | $2,431 | $14 |
| Ranolazine Er | 20 | $1,985 | $99 |
| Atorvastatin | 120 | $1,372 | $11 |
| Losartan | 126 | $1,353 | $11 |
| Metoprolol | 103 | $1,303 | $13 |
| Clopidogrel | 102 | $1,245 | $12 |
| Amiodarone | 17 | $1,219 | $72 |
| Ezetimibe | 14 | $1,111 | $79 |
| Carvedilol | 85 | $945 | $11 |
| Nitroglycerin | 35 | $844 | $24 |
| Amlodipine Besylate | 161 | $761 | $5 |
| Hydralazine | 32 | $689 | $22 |
| Lisinopril | 70 | $607 | $9 |
| Rosuvastatin | 41 | $516 | $13 |
| Valsartan | 15 | $507 | $34 |
| Simvastatin | 35 | $403 | $12 |
| Labetalol | 40 | $397 | $10 |
| Diltiazem | 16 | $348 | $22 |
| Isosorbide Mononitrate Er | 29 | $309 | $11 |
| Levothyroxine | 20 | $299 | $15 |
| Warfarin | 40 | $292 | $7 |
| Irbesartan | 13 | $289 | $22 |
| Furosemide | 49 | $254 | $5 |
| Levetiracetam | 16 | $209 | $13 |
| Pravastatin | 16 | $206 | $13 |
| Hydrochlorothiazide | 19 | $163 | $9 |
| Omeprazole | 14 | $162 | $12 |
| Pantoprazole | 15 | $123 | $8 |
| Tamsulosin | 18 | $104 | $6 |
| Clonidine | 13 | $70 | $5 |
| Acyclovir | 14 | $58 | $4 |
| Metformin | 20 | $47 | $2 |
Year by year
| 2024 | 2,030 | 304 | 0% (0) | 14% | $358,748 |
| 2023 | 1,702 | 265 | 0% (0) | None | $328,304 |
| 2022 | 1,687 | 253 | 0% (0) | None | $274,955 |
| 2021 | 1,636 | 243 | None | 13% | $218,982 |
| 2020 | 1,533 | 220 | 0% (0) | 14% | $176,050 |
| 2019 | 1,775 | 201 | None | 13% | $187,013 |
| 2018 | 1,862 | 201 | 0% (0) | 13% | $180,790 |
| 2017 | 2,148 | 215 | None | 14% | $181,761 |
| 2016 | 2,104 | 242 | None | None | $167,515 |
| 2015 | 1,854 | 207 | 1% (13) | None | $118,461 |
| 2014 | 1,884 | 194 | 1% (13) | None | $128,620 |
| 2013 | 2,274 | 197 | 1% (23) | None | $140,199 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 35 drugs
| Eliquis | 106 | $141,796 | $1,338 |
| Entresto | 24 | $44,610 | $1,859 |
| Brilinta | 27 | $32,091 | $1,189 |
| Xarelto | 24 | $25,233 | $1,051 |
| Diltiazem 12hr Er | 25 | $6,596 | $264 |
| Ranolazine Er | 17 | $6,028 | $355 |
| Dabigatran Etexilate | 13 | $4,532 | $349 |
| Metoprolol | 151 | $4,030 | $27 |
| Amiodarone | 17 | $3,312 | $195 |
| Nitroglycerin | 51 | $2,619 | $51 |
| Clopidogrel | 100 | $2,379 | $24 |
| Amlodipine Besylate | 127 | $2,070 | $16 |
| Losartan | 115 | $1,845 | $16 |
| Atorvastatin | 109 | $1,558 | $14 |
| Carvedilol | 78 | $1,425 | $18 |
| Metoprolol | 96 | $1,424 | $15 |
| Rosuvastatin | 33 | $1,095 | $33 |
| Hydralazine | 18 | $1,063 | $59 |
| Lisinopril | 58 | $1,041 | $18 |
| Clonidine | 11 | $734 | $67 |
| Diltiazem | 13 | $649 | $50 |
| Digoxin | 22 | $635 | $29 |
| Isosorbide Mononitrate Er | 22 | $592 | $27 |
| Irbesartan | 17 | $581 | $34 |
| Warfarin | 27 | $542 | $20 |
| Pravastatin | 27 | $510 | $19 |
| Levothyroxine | 17 | $469 | $28 |
| Simvastatin | 24 | $442 | $18 |
| Labetalol | 12 | $329 | $27 |
| Metformin | 24 | $250 | $10 |
| Terazosin | 11 | $227 | $21 |
| Pantoprazole | 12 | $122 | $10 |
| Hydrochlorothiazide | 12 | $114 | $10 |
| Furosemide | 14 | $100 | $7 |
| Glipizide | 14 | $90 | $6 |
2022: 30 drugs
| Eliquis | 95 | $94,857 | $998 |
| Xarelto | 43 | $49,020 | $1,140 |
| Entresto | 27 | $33,570 | $1,243 |
| Brilinta | 39 | $32,628 | $837 |
| Ranolazine Er | 14 | $4,284 | $306 |
| Metoprolol | 134 | $3,191 | $24 |
| Clopidogrel | 110 | $2,291 | $21 |
| Nitroglycerin | 46 | $2,048 | $45 |
| Losartan | 107 | $1,776 | $17 |
| Ezetimibe | 13 | $1,750 | $135 |
| Carvedilol | 90 | $1,579 | $18 |
| Atorvastatin | 95 | $1,442 | $15 |
| Valsartan | 12 | $1,294 | $108 |
| Amlodipine Besylate | 129 | $1,293 | $10 |
| Amiodarone | 27 | $1,249 | $46 |
| Metoprolol | 98 | $984 | $10 |
| Pravastatin | 25 | $647 | $26 |
| Rosuvastatin | 26 | $536 | $21 |
| Lisinopril | 53 | $500 | $9 |
| Hydralazine | 17 | $486 | $29 |
| Isosorbide Mononitrate Er | 26 | $441 | $17 |
| Warfarin | 28 | $434 | $15 |
| Digoxin | 12 | $389 | $32 |
| Levothyroxine | 14 | $270 | $19 |
| Simvastatin | 26 | $241 | $9 |
| Terazosin | 13 | $238 | $18 |
| Metformin | 29 | $196 | $7 |
| Clonidine | 13 | $183 | $14 |
| Furosemide | 17 | $144 | $8 |
| Glipizide | 11 | $58 | $5 |
2021: 38 drugs
| Eliquis | 74 | $75,396 | $1,019 |
| Xarelto | 34 | $39,659 | $1,166 |
| Brilinta | 40 | $27,844 | $696 |
| Entresto | 14 | $19,232 | $1,374 |
| Metoprolol | 123 | $3,075 | $25 |
| Nitroglycerin | 44 | $2,420 | $55 |
| Ezetimibe | 14 | $1,970 | $141 |
| Atorvastatin | 120 | $1,890 | $16 |
| Amiodarone | 21 | $1,865 | $89 |
| Losartan | 84 | $1,686 | $20 |
| Valsartan | 11 | $1,598 | $145 |
| Clopidogrel | 109 | $1,538 | $14 |
| Ranolazine Er | 14 | $1,409 | $101 |
| Clonidine | 11 | $1,307 | $119 |
| Telmisartan | 15 | $1,102 | $73 |
| Carvedilol | 72 | $1,035 | $14 |
| Metoprolol | 112 | $1,022 | $9 |
| Amlodipine Besylate | 117 | $946 | $8 |
| Diltiazem 24hr Er (Cd) | 15 | $873 | $58 |
| Rosuvastatin | 19 | $695 | $37 |
| Diltiazem 24hr Er | 11 | $687 | $62 |
| Pravastatin | 20 | $581 | $29 |
| Warfarin | 34 | $569 | $17 |
| Hydralazine | 16 | $504 | $32 |
| Lisinopril | 53 | $480 | $9 |
| Isosorbide Mononitrate Er | 24 | $462 | $19 |
| Terazosin | 20 | $374 | $19 |
| Simvastatin | 39 | $331 | $8 |
| Nifedipine Er | 12 | $313 | $26 |
| Levothyroxine | 14 | $296 | $21 |
| Meclizine | 11 | $259 | $24 |
| Omeprazole | 11 | $249 | $23 |
| Allopurinol | 12 | $243 | $20 |
| Metformin | 22 | $231 | $11 |
| Clonidine | 13 | $150 | $12 |
| Atenolol | 15 | $119 | $8 |
| Furosemide | 16 | $109 | $7 |
| Glipizide | 11 | $108 | $10 |
2020: 31 drugs
| Eliquis | 55 | $52,994 | $964 |
| Xarelto | 31 | $38,179 | $1,232 |
| Brilinta | 25 | $18,178 | $727 |
| Amiodarone | 20 | $2,427 | $121 |
| Atorvastatin | 113 | $2,103 | $19 |
| Metoprolol | 88 | $2,064 | $23 |
| Ezetimibe | 12 | $1,918 | $160 |
| Nitroglycerin | 38 | $1,723 | $45 |
| Losartan | 75 | $1,394 | $19 |
| Diltiazem 24hr Er (Cd) | 26 | $1,302 | $50 |
| Clopidogrel | 101 | $1,217 | $12 |
| Rosuvastatin | 20 | $973 | $49 |
| Levothyroxine | 31 | $957 | $31 |
| Carvedilol | 61 | $739 | $12 |
| Telmisartan | 12 | $720 | $60 |
| Amlodipine Besylate | 99 | $679 | $7 |
| Metoprolol | 97 | $671 | $7 |
| Lisinopril | 80 | $608 | $8 |
| Diltiazem | 12 | $532 | $44 |
| Pravastatin | 20 | $484 | $24 |
| Isosorbide Mononitrate Er | 22 | $452 | $21 |
| Warfarin | 35 | $402 | $11 |
| Pioglitazone | 11 | $350 | $32 |
| Simvastatin | 50 | $315 | $6 |
| Meclizine | 11 | $250 | $23 |
| Metformin | 19 | $186 | $10 |
| Atenolol | 20 | $180 | $9 |
| Clonidine | 16 | $157 | $10 |
| Furosemide | 32 | $155 | $5 |
| Allopurinol | 12 | $133 | $11 |
| Benazepril | 12 | $99 | $8 |
2019: 36 drugs
| Eliquis | 51 | $46,082 | $904 |
| Xarelto | 31 | $33,511 | $1,081 |
| Brilinta | 40 | $31,519 | $788 |
| Atorvastatin | 129 | $2,604 | $20 |
| Metoprolol | 65 | $2,503 | $39 |
| Telmisartan | 16 | $2,123 | $133 |
| Ezetimibe | 12 | $1,814 | $151 |
| Losartan | 110 | $1,476 | $13 |
| Clopidogrel | 89 | $1,394 | $16 |
| Nitroglycerin | 34 | $1,298 | $38 |
| Amlodipine Besylate | 116 | $1,184 | $10 |
| Amiodarone | 15 | $1,069 | $71 |
| Carvedilol | 83 | $1,066 | $13 |
| Diltiazem 24hr Er (Cd) | 20 | $1,000 | $50 |
| Rosuvastatin | 18 | $961 | $53 |
| Levothyroxine | 32 | $915 | $29 |
| Lisinopril | 95 | $872 | $9 |
| Metoprolol | 102 | $794 | $8 |
| Isosorbide Mononitrate Er | 30 | $625 | $21 |
| Warfarin | 65 | $617 | $9 |
| Pravastatin | 31 | $615 | $20 |
| Diltiazem | 12 | $475 | $40 |
| Simvastatin | 57 | $440 | $8 |
| Allopurinol | 14 | $409 | $29 |
| Cartia Xt | 17 | $372 | $22 |
| Clonidine | 17 | $337 | $20 |
| Metformin | 30 | $311 | $10 |
| Finasteride | 12 | $253 | $21 |
| Atenolol | 23 | $203 | $9 |
| Pantoprazole | 20 | $196 | $10 |
| Tamsulosin | 11 | $196 | $18 |
| Furosemide | 31 | $193 | $6 |
| Benazepril | 23 | $180 | $8 |
| Gabapentin | 14 | $176 | $13 |
| Famotidine | 11 | $166 | $15 |
| Hydrochlorothiazide | 11 | $18 | $2 |
2018: 39 drugs
| Brilinta | 56 | $36,995 | $661 |
| Eliquis | 44 | $34,959 | $795 |
| Xarelto | 29 | $27,389 | $944 |
| Ezetimibe | 14 | $3,495 | $250 |
| Metoprolol | 99 | $3,175 | $32 |
| Prasugrel | 14 | $1,988 | $142 |
| Atorvastatin | 94 | $1,873 | $20 |
| Diltiazem 24hr Er (Cd) | 25 | $1,829 | $73 |
| Clopidogrel | 104 | $1,585 | $15 |
| Amiodarone | 19 | $1,418 | $75 |
| Losartan | 114 | $1,384 | $12 |
| Nitroglycerin | 29 | $1,200 | $41 |
| Levothyroxine | 36 | $1,163 | $32 |
| Warfarin | 100 | $1,071 | $11 |
| Amlodipine Besylate | 113 | $935 | $8 |
| Isosorbide Mononitrate Er | 32 | $903 | $28 |
| Carvedilol | 75 | $891 | $12 |
| Rosuvastatin | 30 | $784 | $26 |
| Digoxin | 12 | $749 | $62 |
| Lisinopril | 81 | $656 | $8 |
| Metoprolol | 71 | $641 | $9 |
| Pravastatin | 31 | $621 | $20 |
| Valsartan | 14 | $615 | $44 |
| Cartia Xt | 19 | $514 | $27 |
| Simvastatin | 61 | $470 | $8 |
| Furosemide | 55 | $452 | $8 |
| Allopurinol | 15 | $421 | $28 |
| Pantoprazole | 23 | $301 | $13 |
| Finasteride | 14 | $282 | $20 |
| Benazepril | 33 | $252 | $8 |
| Metformin | 23 | $243 | $11 |
| Losartan-Hydrochlorothiazide | 11 | $238 | $22 |
| Atenolol | 19 | $226 | $12 |
| Gabapentin | 18 | $204 | $11 |
| Clonidine | 20 | $163 | $8 |
| Omeprazole | 11 | $130 | $12 |
| Famotidine | 12 | $110 | $9 |
| Jantoven | 11 | $60 | $5 |
| Hydrochlorothiazide | 15 | $40 | $3 |
2017: 39 drugs
| Brilinta | 60 | $33,566 | $559 |
| Eliquis | 25 | $17,265 | $691 |
| Xarelto | 18 | $15,865 | $881 |
| Ezetimibe | 12 | $6,489 | $541 |
| Omega-3 Acid Ethyl Esters | 12 | $3,805 | $317 |
| Metoprolol | 78 | $2,581 | $33 |
| Amiodarone | 36 | $2,452 | $68 |
| Diltiazem 12hr Er | 26 | $2,369 | $91 |
| Rosuvastatin | 33 | $2,297 | $70 |
| Valsartan | 22 | $1,837 | $84 |
| Atorvastatin | 82 | $1,561 | $19 |
| Clopidogrel | 123 | $1,536 | $12 |
| Warfarin | 115 | $1,446 | $13 |
| Levothyroxine | 39 | $1,255 | $32 |
| Nitroglycerin | 26 | $1,115 | $43 |
| Diltiazem 24hr Er | 26 | $1,068 | $41 |
| Losartan | 108 | $988 | $9 |
| Carvedilol | 86 | $901 | $10 |
| Amlodipine Besylate | 100 | $864 | $9 |
| Lisinopril | 104 | $830 | $8 |
| Isosorbide Mononitrate Er | 29 | $665 | $23 |
| Metoprolol | 92 | $637 | $7 |
| Pravastatin | 30 | $555 | $19 |
| Simvastatin | 80 | $532 | $7 |
| Allopurinol | 12 | $522 | $43 |
| Furosemide | 70 | $506 | $7 |
| Pantoprazole | 36 | $466 | $13 |
| Fenofibrate | 11 | $399 | $36 |
| Omeprazole | 18 | $354 | $20 |
| Clonidine | 35 | $296 | $8 |
| Atenolol | 31 | $292 | $9 |
| Gabapentin | 23 | $272 | $12 |
| Metformin | 28 | $270 | $10 |
| Montelukast | 11 | $256 | $23 |
| Benazepril | 27 | $229 | $8 |
| Glipizide | 29 | $215 | $7 |
| Hydrochlorothiazide | 22 | $100 | $5 |
| Donepezil | 11 | $87 | $8 |
| Famotidine | 17 | $73 | $4 |
2016: 38 drugs
| Brilinta | 51 | $24,484 | $480 |
| Eliquis | 41 | $17,471 | $426 |
| Zetia | 21 | $15,946 | $759 |
| Effient | 25 | $12,643 | $506 |
| Xarelto | 17 | $9,551 | $562 |
| Crestor | 22 | $7,168 | $326 |
| Valsartan | 30 | $3,390 | $113 |
| Atorvastatin | 89 | $2,439 | $27 |
| Clopidogrel | 134 | $2,319 | $17 |
| Metoprolol | 85 | $2,163 | $25 |
| Nifedipine Er | 18 | $2,096 | $116 |
| Nitrostat | 26 | $1,711 | $66 |
| Bystolic | 14 | $1,548 | $111 |
| Carvedilol | 112 | $1,500 | $13 |
| Losartan | 105 | $1,090 | $10 |
| Levothyroxine | 33 | $1,017 | $31 |
| Amlodipine Besylate | 95 | $1,002 | $11 |
| Warfarin | 83 | $991 | $12 |
| Fenofibrate | 23 | $971 | $42 |
| Isosorbide Mononitrate Er | 32 | $887 | $28 |
| Simvastatin | 90 | $848 | $9 |
| Amiodarone | 39 | $759 | $19 |
| Metoprolol | 92 | $746 | $8 |
| Lisinopril | 108 | $725 | $7 |
| Pravastatin | 21 | $651 | $31 |
| Furosemide | 75 | $617 | $8 |
| Clonidine | 35 | $437 | $12 |
| Diltiazem 24hr Er | 12 | $412 | $34 |
| Atenolol | 46 | $389 | $8 |
| Benazepril | 32 | $290 | $9 |
| Metformin | 36 | $266 | $7 |
| Omeprazole | 17 | $247 | $15 |
| Ranitidine | 13 | $156 | $12 |
| Pantoprazole | 15 | $95 | $6 |
| Gabapentin | 12 | $93 | $8 |
| Glipizide | 13 | $86 | $7 |
| Hydrochlorothiazide | 20 | $77 | $4 |
| Lisinopril-Hydrochlorothiazide | 12 | $76 | $6 |
2015: 40 drugs
| Brilinta | 30 | $12,871 | $429 |
| Zetia | 20 | $12,359 | $618 |
| Effient | 15 | $8,619 | $575 |
| Crestor | 18 | $6,583 | $366 |
| Pradaxa | 13 | $4,174 | $321 |
| Clopidogrel | 149 | $2,778 | $19 |
| Bystolic | 23 | $2,661 | $116 |
| Nifedipine Er | 21 | $2,311 | $110 |
| Amlodipine-Valsartan | 15 | $2,267 | $151 |
| Metoprolol | 58 | $1,931 | $33 |
| Atorvastatin | 70 | $1,861 | $27 |
| Amiodarone | 38 | $1,274 | $34 |
| Carvedilol | 88 | $1,147 | $13 |
| Isosorbide Mononitrate Er | 53 | $1,049 | $20 |
| Losartan | 98 | $1,022 | $10 |
| Warfarin | 70 | $1,012 | $14 |
| Digoxin | 17 | $986 | $58 |
| Valsartan | 15 | $973 | $65 |
| Pravastatin | 28 | $887 | $32 |
| Nitrostat | 24 | $885 | $37 |
| Levothyroxine | 27 | $866 | $32 |
| Metoprolol | 84 | $809 | $10 |
| Fenofibrate | 12 | $800 | $67 |
| Amlodipine Besylate | 72 | $695 | $10 |
| Lisinopril | 69 | $658 | $10 |
| Simvastatin | 73 | $642 | $9 |
| Potassium Chloride | 11 | $517 | $47 |
| Glipizide | 35 | $341 | $10 |
| Metformin | 31 | $326 | $11 |
| Furosemide | 74 | $325 | $4 |
| Atenolol | 49 | $304 | $6 |
| Omeprazole | 16 | $302 | $19 |
| Clonidine | 28 | $255 | $9 |
| Pantoprazole | 13 | $219 | $17 |
| Benazepril | 22 | $207 | $9 |
| Hydrochlorothiazide | 17 | $100 | $6 |
| Irbesartan | 11 | $98 | $9 |
| Quinapril | 11 | $76 | $7 |
| Terazosin | 12 | $74 | $6 |
| Enalapril Maleate | 13 | $28 | $2 |
2014: 39 drugs
| Diovan | 37 | $14,409 | $389 |
| Zetia | 26 | $12,525 | $482 |
| Effient | 18 | $10,274 | $571 |
| Crestor | 22 | $8,568 | $389 |
| Clopidogrel | 151 | $3,856 | $26 |
| Bystolic | 25 | $2,899 | $116 |
| Nifedipine Er | 22 | $2,452 | $111 |
| Atorvastatin | 93 | $2,324 | $25 |
| Metoprolol | 42 | $1,792 | $43 |
| Isosorbide Mononitrate Er | 45 | $1,646 | $37 |
| Amiodarone | 30 | $1,619 | $54 |
| Nateglinide | 15 | $1,391 | $93 |
| Pravastatin | 30 | $1,197 | $40 |
| Fenofibrate | 15 | $1,134 | $76 |
| Losartan | 78 | $1,124 | $14 |
| Digox | 30 | $1,098 | $37 |
| Carvedilol | 60 | $987 | $16 |
| Lisinopril | 92 | $935 | $10 |
| Simvastatin | 85 | $901 | $11 |
| Amlodipine Besylate | 98 | $742 | $8 |
| Cilostazol | 19 | $698 | $37 |
| Digoxin | 19 | $681 | $36 |
| Levothyroxine | 28 | $661 | $24 |
| Warfarin | 47 | $647 | $14 |
| Metoprolol | 90 | $477 | $5 |
| Nitrostat | 18 | $475 | $26 |
| Metformin | 43 | $460 | $11 |
| Potassium Chloride | 13 | $429 | $33 |
| Omeprazole | 16 | $401 | $25 |
| Glipizide | 36 | $385 | $11 |
| Clonidine | 43 | $367 | $9 |
| Doxazosin Mesylate | 13 | $354 | $27 |
| Furosemide | 67 | $352 | $5 |
| Atenolol | 46 | $317 | $7 |
| Allopurinol | 17 | $142 | $8 |
| Triamterene-Hydrochlorothiazid | 15 | $92 | $6 |
| Quinapril | 12 | $86 | $7 |
| Hydrochlorothiazide | 12 | $48 | $4 |
| Enalapril Maleate | 11 | $25 | $2 |
2013: 43 drugs
| Diovan | 53 | $16,857 | $318 |
| Zetia | 39 | $11,667 | $299 |
| Crestor | 37 | $11,425 | $309 |
| Clopidogrel | 157 | $10,349 | $66 |
| Effient | 15 | $9,210 | $614 |
| Atorvastatin | 104 | $3,919 | $38 |
| Bystolic | 29 | $3,280 | $113 |
| Pacerone | 12 | $2,612 | $218 |
| Losartan | 104 | $2,443 | $23 |
| Metoprolol | 38 | $2,222 | $58 |
| Isosorbide Mononitrate Er | 54 | $2,145 | $40 |
| Valsartan-Hydrochlorothiazide | 12 | $1,543 | $129 |
| Simvastatin | 112 | $1,377 | $12 |
| Carvedilol | 73 | $1,271 | $17 |
| Nifedipine Er | 29 | $1,117 | $39 |
| Metoprolol | 116 | $943 | $8 |
| Warfarin | 89 | $923 | $10 |
| Amiodarone | 43 | $874 | $20 |
| Pravastatin | 35 | $817 | $23 |
| Nateglinide | 12 | $781 | $65 |
| Cilostazol | 17 | $779 | $46 |
| Lisinopril | 76 | $760 | $10 |
| Amlodipine Besylate-Benazepril | 13 | $754 | $58 |
| Amlodipine Besylate | 84 | $747 | $9 |
| Omeprazole | 25 | $744 | $30 |
| Nitrostat | 29 | $667 | $23 |
| Levothyroxine | 37 | $605 | $16 |
| Glipizide | 50 | $567 | $11 |
| Furosemide | 91 | $538 | $6 |
| Metformin | 43 | $514 | $12 |
| Glimepiride | 24 | $500 | $21 |
| Digox | 54 | $477 | $9 |
| Potassium Chloride | 14 | $455 | $32 |
| Diltiazem 24hr Er | 17 | $423 | $25 |
| Atenolol | 38 | $390 | $10 |
| Clonidine | 37 | $280 | $8 |
| Doxazosin Mesylate | 17 | $266 | $16 |
| Triamterene-Hctz | 16 | $173 | $11 |
| Hydrochlorothiazide | 24 | $162 | $7 |
| Allopurinol | 26 | $144 | $6 |
| Quinapril | 11 | $92 | $8 |
| Enalapril Maleate | 13 | $88 | $7 |
| Alprazolam | 17 | $88 | $5 |
Money from drug and device companies
$382 in 2025
| 2025 | 8 | 19 | None | $382 |
| 2024 | 8 | 17 | None | $345 |
| 2023 | 8 | 15 | None | $355 |
| 2022 | 6 | 9 | None | $265 |
| 2021 | 5 | 7 | None | $145 |
| 2020 | 4 | 6 | None | $153 |
| 2019 | 4 | 38 | None | $406 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| E.R. Squibb & Sons L.L.C. | Eliquis | $141 | 8 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $86 | 3 payments
|
| Amgen | Repatha | $37 | 2 payments
|
| Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor | $32 | 2 payments
|
| GlaxoSmithKline | Arexvy | $25 | 1 payment
|
| Abbott Laboratories | Cardiomems | $22 | 1 payment
|
See all 19 published payments
| Bayer Healthcare Pharmaceuticals | Meals · 2025-12-18 | Kerendia | $33 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-26 | Eliquis | $14 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-11-13 | Kerendia | $28 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-06 | Eliquis | $19 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-06 | Eliquis | $5 |
| GlaxoSmithKline | Meals · 2025-10-30 | Arexvy | $25 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-10-06 | Eliquis | $31 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-10-02 | Kerendia | $25 |
| Abbott Laboratories | Meals · 2025-09-23 | Cardiomems | $22 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-09-04 | Eliquis | $15 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-08-07 | Eliquis | $19 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-08-07 | Eliquis | $4 |
| Amgen | Meals · 2025-07-24 | Repatha | $20 |
| Baxter Healthcare | Meals · 2025-06-12 | Hillrom - Carnation Ambulatory Monitor | $15 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-06-05 | Eliquis | $34 |
| Novo Nordisk | Meals · 2025-05-29 | Wegovy | $21 |
| Boston Scientific | Meals · 2025-05-01 | Watchman Flx | $18 |
| Amgen | Meals · 2025-04-03 | Repatha | $17 |
| Baxter Healthcare | Meals · 2025-03-21 | Hillrom - Carnation Ambulatory Monitor | $17 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $345
| Novartis Pharmaceuticals | Leqvio | $148 | 8 payments
|
| Pfizer | Eliquis | $47 | 2 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $36 | 2 payments
|
| Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor | $26 | 1 payment
|
| Kiniksa Pharmaceuticals International plc | Arcalyst | $26 | 1 payment
|
| Amgen | Repatha | $26 | 1 payment
|
| Novo Nordisk | Ozempic | $19 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $17 | 1 payment
|
2023: $355
| Novartis Pharmaceuticals | Entresto | $113 | 5 payments
|
| Pfizer | Eliquis | $75 | 3 payments
|
| Merck Sharp & Dohme | Verquvo | $50 | 2 payments
|
| Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor | $35 | 1 payment
|
| Amgen | Repatha | $25 | 1 payment
|
| Abbott Laboratories | Mitraclip | $21 | 1 payment
|
| Novo Nordisk | Rybelsus | $21 | 1 payment
|
| Boston Scientific | Watchman Flx | $15 | 1 payment
|
2022: $265
| Medtronic | Linq II | $115 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $48 | 3 payments
|
| Boston Scientific | Watchman Access System | $41 | 1 payment
|
| Novo Nordisk | Rybelsus | $31 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $16 | 1 payment
|
| Pfizer | Eliquis | $13 | 1 payment
|
2021: $145
| Abbott Laboratories | Confirm Rx | $61 | 2 payments
|
| Novartis Pharmaceuticals | Entresto | $33 | 2 payments
|
| Amgen | Repatha | $21 | 1 payment
|
| Pfizer | Eliquis | $16 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $14 | 1 payment
|
2020: $153
| Bardy Diagnostics | Carnation Ambulatory Monitor | $82 | 2 payments
|
| Medtronic Vascular | Micra | $31 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $22 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $18 | 1 payment
|
2019: $406
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $234 | 33 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve | $106 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $52 | 3 payments
|
| Novartis Pharmaceuticals | Entresto | $15 | 1 payment
|
Checkups this office reported
2 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Patients can see their records onlinePatients who were given electronic access to their health information | 96%That's most of the people this applied to. | 445 |
| Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper | 91%That's most of the people this applied to. | 327 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Did a security review of patient data
- Exchanges records both ways with other health systems
- Implementation of improvements that contribute to more timely communication of test results
- Implementation of medication management practice improvements
- Reports cases to public health electronically
- Exempt from immunization registry reporting
- Exempt from query of the prescription drug monitoring program (pdmp)
Professional record
- NPI
- 1851334403
- Licence
- CA A32226California A32226: Delinquent · expires 2025-11-30
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00372260
- Taxonomy
- Federal specialty code 174400000X (174400000X)
- Mailing address
- 200 Jose Figueres Ave, Suite 365, San Jose, CA, 95116
- NPI first listed
- 2006-06-13
- NPI last updated
- 2017-02-13
This is when the NPI record was last certified, not a medical board exam.